No mutations found by RET mutation scanning in sporadic and hereditary neuroblastoma

Human Genetics

Volumn 97, Issue 3, 1996, Pages 362-364

  Hofstra, Robert M W ^a   Cheng, Ngan Ching ^b   Hansen, Claus ^c   Stulp, Rein P ^a   Stelwagen, Tineke ^a   Clausen, Niels ^d   Tommerup, Niels ^c   Caron, Huib ^b,e   Westerveld, Andries ^b   Versteeg, Rogier ^b   Buys, Charles H C M ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c JOHN F KENNEDY INSTITUTE   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; CELL MIGRATION; CONTROLLED STUDY; GENE MUTATION; HIRSCHSPRUNG DISEASE; HUMAN; HUMAN CELL; NEURAL CREST CELL; NEUROBLASTOMA; NEUTRAL GENE THEORY; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTO ONCOGENE; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 13344262692     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02185773     Document Type: Article

References (31)

1. Biedler JL, Helson L, Spenler BA (1973) Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33:2643-2652
2. Brodeur GM, Sekhon GS, Goldstein MN (1977) Chromosomal abberations in human neuroblastomas. Cancer 40:2256-2263
3. Carlson KM, Dou S, Chi D, Scavarda N, Toshima K, Jackson CE, Wells SA, Goodfellow PJ, Donis-Keller H (1994) Single missense mutation in the tyrosine kinase catalytic domain of the RET proto-oncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci USA 91:1579-1583
4. Caron HN, van Sluis P, van Hoeve M, de Kraker J, Bras JH, Slater RS, Mannens M, Voute PA, Westerveld A, Versteeg R (1993) Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nature Genet 4:187-190
5. Caron HN, van Sluis P, van Roy N, de Kraker J, Speleman F, Voute PA, Westerveld A, Slater R, Versteeg R (1994) Recurrent 1:17 translocation in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity. Am J Hum Genet 55:341-347
6. Ceccherini I, Hofstra RMW, Yin L, Stulp RP, Barone V, Stelwagen T, Bocciardi R, Nijveen H, Bolino A, Seri M, Ronchetto P, Pasini B, Bozzano B, Buys CHCM, Romeo G (1994) DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the RET proto-oncogene. Oncogene 9:3025-3029
7. Cheng NC, van Roy N, Chan A, Beitsma M, Westerveld A, Speleman F, Versteeg R (1995) Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region only one of which is associated with N-myc amplification. Oncogene 10:291-297
8. Clausen N, Andersson P, Tommerup N (1989) Familial occurrence of neuroblastoma, von Recklinghausen's neurofibromatosis. Hirschsprung's aganglionosis, and jaw-winking syndrome. Acta Paediatr Scan 78:736-741
9. Van Dommeleln MW, Peters van der Sanden MJH, Molenaar JC, Meijers C. Pattern of malformations and dysmorphisms associated with Hirschsprung disease: an evaluation of 214 patients. Am J Med Genet: in press
10. Donis-Keller H, Dou S, Chi D, Carlson K, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells SA (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 7:851-856
11. Edery P, Lyonnet S, Mulligan LM, Pelet A, Dow E, Abel L, Holder S, Nihoul-Fékéte C, Ponder BAJ, Munnich A (1994) Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature 367:378-380
12. Eng C, Smith DP, Mulligan LM, Nagai MA, Healey CS, Ponder MA, Gardner E, Scheumann FW, Jackson CE, Tunnacliffe A, Ponder BAJ (1994) Point mutations within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumors. Hum Mol Genet 3: 237-241
13. Fong CT, Dracopoli NC, White PS, Merrill PT, Griffith RC, Housman DE, Brodeur GM (1989) Loss of heterozygosity for the short arm of chromosome I in human neuroblastoma: correlation with N-myc amplification. Proc Natl Acad Sci USA 86: 3753-3757
14. Hofstra RMW, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Yin L, Pasini B, Höppener JWM, Ploos van Amstel HK, Romeo G, Lips CJM, Buys CHCM (1994) A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367:375-376
15. Ikeda I, Ishizaka Y, Tahira T, Suzuki T, Onda M, Sugimura T, Nagao M (1990) Specific expression of the RET proto-oncogene in human neuroblastoma cell lines. Oncogene 5:1291-1296
16. Itoh F, Ishizaka Y, Tahira T, Yamamoto M, Miya A, Imai K, Yachi A, Shinichiro T, Sugimura T, Nagao M (1992) Identification and analysis of the RET proto-oncogene promoter region in neuroblastoma cell lines and medullary thyroid carcinomas from MEN 2A patients. Oncogene 7:1201-1206
17. Iwamoto T, Taniguchi M, Wajjwalku W, Nakashima I, Takahashi M (1993) Neuroblastoma in a transgenic mouse carrying a metallothionein/RET fusion gene. Br J Cancer 67:504-507
18. Miya A, Yamamoto M, Morimoto H, Tanaka N, Shin E, Karakawa K, Toyoshima K, Ishizaka Y, Mori T, Takai SI (1992) Expression of the RET proto-oncogene in human medullary thyroid carcinoma and pheochromocytomas of MEN 2A. Henry Ford Hosp Med J 40:215-218
19. Mulligan LM, Kwok JBJ, Healey CS, Elsdon MJ, Eng C, Gardner E. Love DR, Mole SE, Moore J, Papi L, Ponder MA, Telenius H, Tunnacliffe A, Ponder BAJ (1993) Germline mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458-460
20. Nagao M, Ishizaka Y, Nakagawara A, Kohno K, Kuwano M, Tahira T, Itoh F, Ikeda I, Sugimura T (1990) Expression of RET proto-oncogene in human neuroblastomas. Jpn J Cancer Res 81:309-312
21. Pachnis V, Mankoo B, Constantini F (1993) Expression of the C-RET proto-oncogene during mouse embryosenesis. Development 119:1005-1017
22. Romeo G, Ronchetto P, Yin L, Barone V, Seri M, Ceccherini I, Pasini B, Bocciardi R, Lerone M, Kääriäinen H, Martucciello G (1994) Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschspruna's disease. Nature 367:377-378
23. Santoro M, Rosati R, Grieco M, Berlingieri MT, d'Amato GLC, de Franciscis V, Fusco A (1990) The RET proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene 5:1595-1598
24. Sarkar G, Yoon HS, Sommer SS (1992) Screening for mutations by RNA single-strand conformation polymorphism (rSSCP): comparison with DNA-SSCP. Nucleic Acids Res 20:871-878
25. Savelyeva L, Corvi R, Schwab M (1994) Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells Am J Hum Genet 55:334-340
26. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond MD (1985) Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111-1117
27. Tahira T, Ishizaka Y, Itoh F, Nakayasu M, Sugimura T, Nagao M (1991) Expression of the RET proto-oncogene in human neuroblastoma cell lines and its increase during neuronal differentiation induced by retinoic acid. Oncogene 6:2333-2338
28. Takahashi M, Cooper GM (1987) RET transforming gene encodes a fusion protein homologous to tyrosine kinases. Mol Cell Biol 7:1378-1385
29. Takahashi M, Buma Y, Taniguchi M (1991) Identification of the RET proto-oncosene in neuroblastoma and leukemia cells. Oncogene 6:297-301
30. Verloes A, Elmer C, Lacombe D, Heinrichs C, Rebuffat E, Demarquez JL, Moncla A, Adam E (1993) Ondine-Hirschsprung syndrome (Haddad syndrome). Eur J Pediatr 152:75-77
31. Weith A, Martinsson T, Cziepluch C, Bruderlein S, Amler LC, Berthold F, Schwab M (1989) Neuroblastoma consensus deletion maps to 1p361-2. Genes Chromosomes Cancer 1:159-166